Erythropoietic protoporphyria: Altered phenotype after bone marrow transplantation for myelogenous leukemia in a patient heteroallelic for ferrochelatase gene mutations

Journal of the American Academy of Dermatology

Volumn 46, Issue 6, 2002, Pages 861-866

  Poh Fitzpatrick, Maureen B ^a   Wang, Xiuhua ^a   Anderson, Karl E ^b   Bloomer, Joseph R ^c   Bolwell, Brian ^d   Lichtin, Alan Eli ^d  

^a College of Physicians and Surgeons ^*  (United States)

^b University of Texas Medical Branch School of Medicine   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FERROCHELATASE; PROTOPORPHYRIN;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ARTICLE; BONE MARROW TRANSPLANTATION; CANCER REGRESSION; CASE REPORT; ERYTHROPOIETIC PROTOPORPHYRIA; EXON; FEMALE; GENE MUTATION; HUMAN; MISSENSE MUTATION; PHENOTYPE; PHOTOSENSITIVITY DISORDER; PRIORITY JOURNAL;

EID: 0036622095     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1067/mjd.2002.120460     Document Type: Article

References (32)

1. Todd DJ. Erythropoietic protoporphyria. Br J Dermatol 1994;131:751-66.
2. Poh-Fitzpatrick MB. Porphyrias. In: Arndt KA, LeBoit PE, Robinson JK, Wintroub BU, editors. Cutaneous medicine and surgery: an integrated program in dermatology. Philadelphia: WB Saunders; 1995. p. 1753-62.
3. Anderson KE, Sassa S, Bishop DF, Desnick RJ. X-linked sideroblastic anemias and the porphyrias. In: Scriver CR, Beaudet AL, Sly WS, Valle D, Childs B, Vogelstein B, editors. The metabolic and molecular basis of inherited disease. Vol II. New York: McGraw-Hill; 2001. p. 2991-3062.
4. Cox TM. Erythropoietic protoporphyria. J Inherit Metab Dis 1997;20:258-69.
5. Schneider-Yin X, Gouya L, Meier-Weinand A, Deybach JC, Minder E. New insights into the pathogenesis of erythropoietic protoporphyria and their impact on patient care. Eur J Pediatr 2000;159:719-25.
6. Went LN, Klasen EC. Genetic aspect of erythropoietic protoporphyria. Ann Hum Genet 1984;48:105-17.
7. Gouya L, Deybach JC, Lamoril J, et al. Modulation of the phenotype in dominant erythropoietic protoporphyria by a low expression of the normal ferrochelatase allele. Am J Hum Genet 1996;58:292-9.
8. Rüfenacht UB, Gouya L, Schneider-Yin X, et al. Systematic analysis of molecular defects in the ferrochelatase gene from patients with erythropoietic protoporphyria. Am J Hum Genet 1998;62:1341-52.
9. Wang X, Yang L, Kurtz L, et al. Haplotype analysis of families with erythropoietic protoporphyria and novel mutations of the ferrochelatase gene. J Invest Dermatol 1999;113:87-92.
10. Gouya L, Puy H, Lamoril J, et al. Inheritance in erythropoietic protoporphyria: a common wild-type ferrochelatase allelic variant with low expression accounts for clinical manifestation. Blood 1999;93:2105-10.
11. Lamoril J, Boulechfar S, de Verneuil H, Grandchamp B, Nordmann Y, Deybach JC. Human erythropoietic protoporphyria: two point mutations in the ferrochelatase gene. Biochem Biophys Res Comm 1991;181:594-9.
12. Sarkany RPE, Alexander GJMA, Cox TM. Recessive inheritance of erythropoietic protoporphyria with liver failure. Lancet 1994;343:1394-6.
13. Crilley P, Topolsky D, Styler M, et al. Extramedullary toxicity of a conditioning regimen containing busulphan, cyclophosphamide and etoposide in 84 patients undergoing autologous and allogenic bone marrow transplantation. Bone Marrow Transplant 1995;15:361-5.
14. Chao N, Schmidt G, Niland J, et al. Cyclosporine, methotrexate, and prednisone compared with cyclosporine and prednisone for prophylaxis of acute graft-versus-host disease. N Engl J Med 1993;329:1225-30.
15. Piomelli S. A micromethod for free erythrocyte protoporphyrin: the FEP test. J Lab Clin Med 1973;81:932-40.
16. Poh-Fitzpatrick MB, DeLeo VA. Rates of porphyrin disappearance in fluorescent vs. red incandescent light exposure. J Invest Dermatol 1977;69:510-2.
17. Poh-Fitzpatrick MB, Lamola AA. Direct spectrofluorimetry of diluted erythrocytes and plasma: a rapid diagnostic method in primary and secondary porphyrinemias. J Lab Clin Med 1976;87: 362-70.
18. Schwartz S, Stephenson B, Sarkar D. Chromatography on Florisil in the quantitative estimation of urinary and other porphyrins. Clin Chem 1976;22:1057-61.
19. Mauzerall D, Granick S. The occurrence and determination of δ-aminolevulinic acid and porphobilinogen in urine. J Biol Chem 1956;219:435-6.
20. Lockwood WH, Poulos V, Rossi E, Curnow DH. Rapid procedure for fecal porphyrin assay. Clin Chem 1985;31:163-7.
21. Egger NG, Goeger DE, Anderson KE. Effects of chloroquine in hematoporphyrin-treated animals. Chem Biol Interact 1996;102:69-78.
22. Bloomer JR, Weimer MK, Bossenmaier IC, Snover DC, Payne WD, Ascher NL. Liver transplantation in a patient with protoporphyria. Gastroenterology 1989;97:188-94.
23. Knowlton RG, Brown VA, Braman JC, et al. Use of highly polymorphic DNA probes for genotypic analysis following bone marrow transplantation. Blood 1986;68:378-85.
24. ManaitisT, Fritsch EF, Sambrook J. Molecular cloning - a laboratory manual: Cold Spring Harbor Laboratory, 1982.
25. Saiki RK, Chang CA, Levenson CH, et al. Diagnosis of sickle cell anemia and β-thalassemia with enzymatically amplified DNA and nonradioactive allele-specific oligonucleotide probes. N Engl J Med 1988;319:537-41.
26. Bottomley SS, Moore MZ. Acquired erythropoietic protoporphyria and sideroblastic anemia [abstract]. Clin Res 1987;35:38A.
27. Lim HW, Cooper D, Sassa S, Dosik H, Buchness MR, Soter NA. Photosensitivity, abnormal porphyrin profile, and sideroblastic anemia. J Am Acad Dermatol 1992;27:287-92.
28. Rothstein G, Lee GR, Cartwright GE. Sideroblastic anemia with dermal photosensitivity and greatly increased erythrocyte protoporphyrin. N Engl J Med 1969;280:587-90.
29. Sato Y, Motoji T, Yamada O, et al. A case of sideroblastic anemia with dermal photosensitivity and increased erythrocyte protoporphyrin. Rinsho Ketsueki 1981;22:1971-6.
30. Bottomley SS. Porphyrin and iron metabolism in sideroblastic anemia. Semin Hematol 1977;14:169-85.
31. Bennett DD, Stanley WS, Johnson CB. Combined phenotypic and genotypic analysis of ringed sideroblasts in acquired idiopathic sideroblastic anemia. Acta Haematol 1985;73:235-8.
32. Taketani S, Inazawa J, Nakahashi Y, Abe T, Tokunaga R. Structure of the human ferrochelatase gene: exon/intron gene organization and location of the gene to chromosome 18. Eur J Biochem 1992;205:217-22.